{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:44:41Z","timestamp":1793738681507,"version":"4.6.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune checkpoint inhibitors highlight the importance of anticancer immunity. However, their clinical utility and safety are limited by the low response rates and adverse effects. We focused on progesterone (P4), a hormone produced by the placenta during pregnancy, because it has multiple biological activities related to anticancer and immune regulation effects. P4 has a reversible immune regulatory function distinct from that of the stress hormone cortisol, which may drive irreversible immune suppression that promotes T cell exhaustion and apoptosis in patients with cancer. Because the anticancer effect of P4 is induced at higher than physiological concentrations, we aimed to develop a new anticancer drug by encapsulating P4 in liposomes. In this study, we prepared liposome-encapsulated anti-programmed death ligand 1 (PD-L1) antibody-conjugated P4 (Lipo-anti-PD-L1-P4) and evaluated the effects on the growth of MDA-MB-231 cells, a PD-L1-expressing triple-negative breast cancer cell line, <jats:italic>in vitro<\/jats:italic> and in NOG-hIL-4-Tg mice transplanted with human peripheral blood mononuclear cells (humanized mice). Lipo-anti-PD-L1-P4 at physiological concentrations reduced T cell exhaustion and proliferation of MDA-MB-231 <jats:italic>in vitro<\/jats:italic>. Humanized mice bearing MDA-MB-231 cells expressing PD-L1 showed suppressed tumor growth and peripheral tissue inflammation. The proportion of B cells and CD4+ T cells decreased, whereas the proportion of CD8+ T cells increased in Lipo-anti-PD-L1-P4-administrated mice spleens and tumor-infiltrated lymphocytes. Our results suggested that Lipo-anti-PD-L1-P4 establishes a systemic anticancer immune environment with minimal toxicity. Thus, the use of P4 as an anticancer drug may represent a new strategy for cancer treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1173728","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T09:22:48Z","timestamp":1688980968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Construction of the systemic anticancer immune environment in tumour-bearing humanized mouse by using liposome-encapsulated anti-programmed death ligand 1 antibody-conjugated progesterone"],"prefix":"10.3389","volume":"14","author":[{"given":"Yoshie","family":"Kametani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shino","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soga","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagi","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Kirigaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banri","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Maeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Tokeshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Fukase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-specific hla loss and immune escape in lung cancer evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of pd-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by pd-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.977618","article-title":"Three categories of similarities between the placenta and cancer that can aid cancer treatment: cells, the microenvironment, and metabolites","volume":"12","author":"Pang","year":"2022","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00018-022-04377-0","article-title":"Early human trophoblast development: from morphology to function","volume":"79","author":"Gauster","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.3390\/ijms23148003","article-title":"Human chorionic villous differentiation and placental development","volume":"23","author":"Kojima","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmi.2020.10.007","article-title":"Impact of Covid-19 on maternal and neonatal outcomes: a systematic review and meta-analysis","volume":"27","author":"Di Toro","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2020","article-title":"Pregnancy and Covid-19","volume":"101","author":"Wastnedge","year":"2021","journal-title":"Physiol Rev"},{"key":"B10","article-title":"Pregnancy-associated breast cancer\u2013a review analysis","volume":"31","author":"Daniilidis","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01027","article-title":"Physiology and pathophysiology of steroid biosynthesis, transport and metabolism in the human placenta","volume":"9","author":"Chatuphonprasert","year":"2018","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445404","article-title":"Progesterone promotes maternal\u2013fetal tolerance by reducing human maternal T-cell polyfunctionality and inducing a specific cytokine profile","volume":"45","author":"Lissauer","year":"2015","journal-title":"Eur J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.941834","article-title":"Enhanced anti-cancer effects of oestrogen and progesterone Co-therapy against colorectal cancer in males","volume":"13","author":"Mahbub","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/pharmaceutics13101616","article-title":"Progestins as anticancer drugs and chemosensitizers, new targets and applications","volume":"13","author":"Fedotcheva","year":"2021","journal-title":"Pharmaceutics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030840","article-title":"Progesterone inhibits epithelial-to-Mesenchymal transition in endometrial cancer","volume":"7","author":"van der Horst","year":"2012","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12920-019-0601-9","article-title":"Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mrnas and lncrnas in endometrial cancer cells","volume":"12","author":"Cao","year":"2019","journal-title":"BMC Med Genomics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.05.028","article-title":"Effect of progesterone and its synthetic analogues on the activity of mitochondrial permeability transition pore in isolated rat liver mitochondria","volume":"78","author":"Fedotcheva","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1000728","article-title":"High-progesterone environment preserves T cell competency by evading glucocorticoid effects on immune regulation","volume":"13","author":"Kashiwagi","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1019-4","article-title":"Glucocorticoids promote breast cancer metastasis","volume":"567","author":"Obradovic","year":"2019","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671093","article-title":"Placenta-derived exosomes as a modulator in maternal immune tolerance during pregnancy","volume":"12","author":"Bai","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.717884","article-title":"Immunosuppressive protein signatures carried by syncytiotrophoblast-derived exosomes and their role in human pregnancy","volume":"12","author":"Mincheva-Nilsson","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41598-020-58674-4","article-title":"Clinical efficacy and safety of anti-Pd-1\/Pd-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis","volume":"10","author":"Sun","year":"2020","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0207","article-title":"Nod\/Scid\/Gamma(C)(Null) mouse: an excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.3390\/ijms20246337","article-title":"Humanized mice as an effective evaluation system for peptide vaccines and immune checkpoint inhibitors","volume":"20","author":"Kametani","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179239","article-title":"Nog-Hil-4-Tg, a new humanized mouse model for producing tumor antigen-specific igg antibody by peptide vaccination","volume":"12","author":"Kametani","year":"2017","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12798","DOI":"10.1038\/s41598-021-92311-y","article-title":"Her2-Antigen-Specific humoral immune response in breast cancer lymphocytes transplanted in hu-pbl hil-4 nog mice","volume":"11","author":"Ohno","year":"2021","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.8b00341","article-title":"Development of the ilinp device: fine tuning the lipid nanoparticle size within 10 nm for drug delivery","volume":"3","author":"Kimura","year":"2018","journal-title":"ACS Omega"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-017-0824-6","article-title":"B-cell populations are expanded in breast cancer patients compared with healthy controls","volume":"25","author":"Tsuda","year":"2018","journal-title":"Breast Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s12020-018-1795-x","article-title":"In vitro antitumor activity of progesterone in human adrenocortical carcinoma","volume":"63","author":"Fragni","year":"2019","journal-title":"Endocrine"},{"key":"B32","volume-title":"Introduction to the endocrine system","author":"White","year":"2012"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.022","article-title":"Vesicle-mediated steroid hormone secretion in drosophila melanogaster","volume":"163","author":"Yamanaka","year":"2015","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e20211493","DOI":"10.1084\/jem.20211493","article-title":"Toward an understanding of allogeneic conflict in pregnancy and transplantation","volume":"219","author":"Durgam","year":"2022","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.02.004","article-title":"Hormonal modulation of the immune system - a spotlight on the role of progestogens","volume":"14","author":"Tan","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0489","article-title":"Female steroid hormones use signal transducers and activators of transcription protein-mediated pathways to modulate the expression of T-bet in epithelial cells: a mechanism for local immune regulation in the human reproductive tract","volume":"19","author":"Kawana","year":"2005","journal-title":"Mol endocriology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03017","article-title":"Steroids, pregnancy and fetal development","volume":"10","author":"Solano","year":"2020","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2012.2","article-title":"Current advances in humanized mouse models","volume":"9","author":"Ito","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-animal-020420-033029","article-title":"Potential applications and perspectives of humanized mouse models","volume":"10","author":"Ye","year":"2022","journal-title":"Annu Rev Anim Biosci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111295","article-title":"Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers","volume":"40","author":"Xu","year":"2022","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1084\/jem.20180595","article-title":"Immune regulation by glucocorticoids can be linked to cell type\u2013dependent transcriptional responses","volume":"216","author":"Franco","year":"2019","journal-title":"J Exp Ned"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2019.05.008","article-title":"Regulatory functions of B cells and regulatory plasma cells","volume":"42","author":"Fillatreau","year":"2019","journal-title":"BioMed J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048658","article-title":"Human pregnancy levels of estrogen and progesterone contribute to humoral immunity by activating Tfh\/B cell axis","volume":"51","author":"Monteiro","year":"2021","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e129641","DOI":"10.1172\/jci.insight.129641","article-title":"Tumor infiltrating b-cells signal functional humoral immune responses in breast cancer","volume":"5","author":"Garaud","year":"2019","journal-title":"JCI Insight"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/s41467-022-29753-z","article-title":"T Follicular helper and b cell crosstalk in tertiary lymphoid structures and cancer immunotherapy","volume":"13","author":"Garaud","year":"2022","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049144","article-title":"Differential effects of estradiol and progesterone on human T cell activation in vitro","volume":"51","author":"Papapavlou","year":"2021","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1173728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T09:22:53Z","timestamp":1688980973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1173728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2023.1173728"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1173728","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"article-number":"1173728"}}